VA expands health care to PFAS-exposed veterans without proof
H.R. 3639 — VET PFAS Act · Filed by Michael Lawler (R-NY) · 31 cosponsors · Introduced May 29, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill expands VA health care to veterans and their family members who were exposed to PFAS (per- and polyfluoroalkyl substances, including the chemical PFOA) at military installations, and creates a legal presumption that certain diseases—including high cholesterol, ulcerative colitis, thyroid disease, testicular cancer, kidney cancer, and pregnancy-induced hypertension—are service-connected for PFAS-exposed veterans, eliminating the need to prove causation. The bill also extends presumptive coverage to family members who lived at contaminated installations or were in utero there.
Why we flagged it
The bill's core function is to extend VA hospital care and presumptive disability benefits to a specific population (PFAS-exposed veterans and families) without requiring proof of causation. This is a straightforward entitlement expansion, not a tax provision, deregulation, or appropriations rider.
What the text implies
- The bill ties presumptive coverage for non-PFOA PFAS substances to a 2018 NDAA study (Sec. 316, PL 115–91) that may not yet be complete or may not have reached Congress; the operative trigger and scope of family-member coverage thus depend on an external study's findings and timing, creating potential delays or scope uncertainty.
- Family members' eligibility is contingent on exhausting all third-party claims and remedies (including health-plan contracts) before VA coverage applies, making the VA a payer of last resort; this may create friction with private insurers and delay care while claims are pursued.
- The bill grants the Secretary of Veterans Affairs and the HHS Administrator broad discretion to determine which additional PFAS-related diseases qualify for presumption, potentially allowing future expansion without additional legislation but also creating regulatory uncertainty.
- Annual reporting requirements are limited to a three-year window tied to the 2018 study submission; after that window, reporting obligations end, reducing long-term transparency into program costs and utilization.
Section numbers refer to the bill text the analysis read — linked under Primary records below.
Who it affects
Veterans and military families exposed to a documented environmental contaminant gain access to VA health care and disability benefits without having to prove causation, removing a significant barrier to treatment. The bill does not restrict any citizen rights or remedies; it expands them. The cost is borne by the federal government (VA appropriations), not by the public through reduced protections or higher private costs.
Who stands to gain
- VA (increased appropriations for hospital care and medical services)
- pharmaceutical companies (increased demand for treatments for presumed PFAS-related conditions)
- health care providers (increased VA reimbursements for care to veterans and family members)
Named in the bill
Department of Veterans Affairs, Department of Health and Human Services, Agency for Toxic Substances and Disease Registry, House Committee on Veterans' Affairs, Senate Committee on Veterans' Affairs, Military installations (contaminated with PFAS/PFOA), Reserve components of the Armed Forces
Where it stands
31 cosponsors: 29 Democrats, 2 Republicans.
- May 29, 2025 — Introduced · Congress.gov: “Introduced in House”
- May 29, 2025 — Referred to House Committee on Veterans' Affairs · Congress.gov: “Referred to the House Committee on Veterans' Affairs”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
Money around this bill
1 lobbying clients named this bill on 2 disclosure filings across 2 quarters, Dec 2025 to Jun 2026. Those filings disclosed $310,451 in lobbying spend. A filing names 170 bills on average, so that figure is what each filing reported, not a share belonging to this bill.
More lobbying clients named this bill than 0% of bills with at least one filing.
Michael Lawler, the sponsor, reported $2,081,571 in PAC receipts in the 2026 cycle.
- Disabled American Veterans — $310,451 on 2 filings
Lobbying Disclosure Act filings through Jul 21, 2026. A filing shows who paid to lobby on a bill it names, not what changed.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (9,118 characters) on Aug 13, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 16,222 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
Money — Senate Lobbying Disclosure Act filings whose specific-issue field names this bill for quarters ending Dec 2025 to Jun 2026. A filing's amount is reported whole beside the median number of bills a filing names; it is never divided across them. PAC receipts are FEC-reported contributions to the sponsor's candidate committee in the 2026 cycle.
As of — lobbying records through Jul 21, 2026 · page rendered 2026-10-20.
“VA expands health care to PFAS-exposed veterans without proof” QuorumCivic. https://share.quorumcivic.app/bill/119/hr3639 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.